Targeting cancer with peptide aptamers

Area of Science:

• Oncology
• Biotechnology
• Nanomedicine

Background:

• Cancer chemotherapy seeks targeted agents, including small molecules and biologics.
• Peptide aptamers are emerging biologics with potential to inhibit oncotargets.
• Heat Shock Proteins are among the targets for peptide aptamers.

Purpose of the Study:

• To highlight peptide aptamers as promising cancer targeting agents.
• To discuss challenges and potential solutions for clinical translation.
• To explore the role of nanotechnology in optimizing peptide aptamer delivery.

Main Methods:

• Review of current literature on peptide aptamers in cancer research.
• Analysis of potential oncotargets, including Heat Shock Proteins.
• Discussion of delivery strategies, focusing on nanotechnology applications.

Main Results:

• Peptide aptamers demonstrate potential for specific oncotarget inhibition.
• Nanotechnology offers a viable strategy for enhancing peptide aptamer delivery.
• Clinical translation faces challenges requiring further optimization.

Conclusions:

• Peptide aptamers represent an attractive class of targeted cancer therapeutics.
• Optimized delivery, particularly via nanotechnology, is crucial for clinical success.
• Further research is needed to overcome challenges in peptide aptamer clinical trials.